Dow Jones

43,325.80

0.07%

Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

Regístrate

0G8X

Immunovia Ab (publ) (0G8X)

Immunovia Ab (publ)

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:LSE:0G8X

1 2 3 4 5 6 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
19/12/2024	09:06	PR Newswire (US)	End of the Year 2024 Letter from Immunovia CEO Jeff Borcherding	LSE:0G8X	Immunovia Ab (publ)
04/01/2024	09:59	PR Newswire (US)	Immunovia announces financial calendar for financial year 2024	LSE:0G8X	Immunovia Ab (publ)
21/11/2023	04:40	PR Newswire (US)	Bulletin from the extraordinary general meeting in Immunovia AB	LSE:0G8X	Immunovia Ab (publ)
09/11/2023	02:03	PR Newswire (US)	Immunovia Publishes Interim Report for January-September 2023	LSE:0G8X	Immunovia Ab (publ)
07/11/2023	09:14	PR Newswire (US)	Immunovia successfully completes discovery phase of next-generation test development	LSE:0G8X	Immunovia Ab (publ)
02/11/2023	05:02	PR Newswire (US)	Invitation to Immunovia's Q3 presentation	LSE:0G8X	Immunovia Ab (publ)
27/10/2023	02:06	PR Newswire (US)	CONVENING NOTICE - EXTRAORDINARY GENERAL MEETING IN IMMUNOVIA AB (PUBL)	LSE:0G8X	Immunovia Ab (publ)
03/10/2023	04:01	PR Newswire (US)	Nomination Committee appointed for Immunovia AB (Publ)	LSE:0G8X	Immunovia Ab (publ)
30/08/2023	05:30	PR Newswire (US)	Immunovia Publishes Interim Report for January-June 2023	LSE:0G8X	Immunovia Ab (publ)
23/08/2023	13:08	PR Newswire (US)	Invitation to Immunovia's Q2 presentation	LSE:0G8X	Immunovia Ab (publ)
19/07/2023	11:47	PR Newswire (US)	Immunovia announces updated financial calendar	LSE:0G8X	Immunovia Ab (publ)
12/07/2023	02:15	PR Newswire (US)	Immunovia to Significantly Restructure to Focus Resources on its Next-Generation Blood Test for Pancreatic Cancer Detection	LSE:0G8X	Immunovia Ab (publ)
09/06/2023	03:19	PR Newswire (US)	Chief Executive Officer, Jeff Borcherding, buys Immunovia shares	LSE:0G8X	Immunovia Ab (publ)
31/05/2023	05:16	PR Newswire (US)	Change in number of shares and votes in Immunovia AB (publ)	LSE:0G8X	Immunovia Ab (publ)
26/05/2023	06:43	PR Newswire (US)	Bulletin from the Annual General Meeting in Immunovia AB	LSE:0G8X	Immunovia Ab (publ)
23/05/2023	02:03	PR Newswire (US)	Immunovia Publishes Interim Report for January-March 2023	LSE:0G8X	Immunovia Ab (publ)
22/05/2023	11:55	PR Newswire (US)	Changes to the Nomination Committee's proposal to the Annual General Meeting 2023 in Immunovia AB (publ)	LSE:0G8X	Immunovia Ab (publ)
17/05/2023	03:43	PR Newswire (US)	Invitation to Immunovia's Q1 presentation	LSE:0G8X	Immunovia Ab (publ)
06/05/2023	06:40	PR Newswire (US)	The board member Philipp von Hugo resigns from Immunovia's board at his own request	LSE:0G8X	Immunovia Ab (publ)
30/04/2023	05:17	PR Newswire (US)	Immunovia AB appoints new CEO	LSE:0G8X	Immunovia Ab (publ)
26/04/2023	07:44	PR Newswire (US)	Immunovia to discuss adoption of IMMray™ PanCan-d with key opinion leaders on May 3, 2023	LSE:0G8X	Immunovia Ab (publ)
25/04/2023	02:02	PR Newswire (US)	CONVENING NOTICE - ANNUAL GENERAL MEETING IN IMMUNOVIA AB (publ)	LSE:0G8X	Immunovia Ab (publ)
21/04/2023	10:25	PR Newswire (US)	Immunovia publishes the annual report for 2022	LSE:0G8X	Immunovia Ab (publ)
20/04/2023	01:54	PR Newswire (US)	Immunovia to participate in National Pancreas Foundation Webinar on Biomarkers and Liquid Biopsy for Early Detection of Pancreatic Cancer	LSE:0G8X	Immunovia Ab (publ)
12/04/2023	12:06	PR Newswire (US)	Immunovia announces outcome of the rights issue	LSE:0G8X	Immunovia Ab (publ)
17/03/2023	07:34	PR Newswire (US)	Immunovia publishes prospectus relating to the rights issue	LSE:0G8X	Immunovia Ab (publ)
01/03/2023	01:41	PR Newswire (US)	Immunovia appoints Karl Stone as new chief operating officer to develop R&D and operations	LSE:0G8X	Immunovia Ab (publ)
23/02/2023	01:54	PR Newswire (US)	Immunovia Publishes Full Year Report for 2022	LSE:0G8X	Immunovia Ab (publ)
20/02/2023	08:37	PR Newswire (US)	Invitation to Immunovia's Q4 presentation	LSE:0G8X	Immunovia Ab (publ)
20/02/2023	01:44	PR Newswire (US)	CONVENING NOTICE - EXTRAORDINARY GENERAL MEETING IN IMMUNOVIA AB (publ)	LSE:0G8X	Immunovia Ab (publ)